Ambu A/S EBIT per Share
The EBIT per Share of Ambu A/S (AMBU B.CO) as of Aug 11, 2026 is 2.94 DKK. In the previous year, EBIT per Share was 2.42 DKK — a change of 21.48% (higher).
Get this data via API
Financial Data API
EBIT per Share
2.94DKK
YoY
21.48%
Last updated:
EBIT per Share of Ambu A/S is 2026 2.94 DKK. EBIT per Share of Ambu A/S was 2025 2.42 DKK. It decreases by 21.48% higher compared to the previous year.
Access this data via the Eulerpool API
Ambu A/S Stock analysis
What does Ambu A/S do? Ambu A/S is a Danish company that manufactures and distributes medical products. The company was founded in 1937 and initially specialized in the production of electrodes for medical devices. Over time, Ambu has expanded its business to various medical products.
Ambu's business model is based on the development and marketing of innovative medical products. The company places great value on research and development, investing a significant portion of its revenue into this area each year. Ambu operates seven research and development facilities worldwide and employs over 700 staff in this area.
Ambu operates globally in three divisions: Anaesthesia, Patient Monitoring & Diagnostics, and Emergency Care. In the Anaesthesia division, the company offers products such as anaesthesia masks, ventilation bags, and disposable laryngoscopes. These products are used by anaesthesiologists and intensive care nurses to intubate and ventilate patients.
In the Patient Monitoring & Diagnostics division, the company offers products such as electrodes, probes, and other accessories for monitoring vital parameters. Ambu's patient monitoring systems enable the monitoring of patients in hospitals, clinics, and other medical facilities.
In the Emergency Care division, Ambu offers products such as defibrillators, ventilation devices, and portable ventilation bags that are used by emergency services, paramedics, and other emergency medical services. Ambu's products are designed to provide life-saving assistance in emergency situations.
Ambu is a leading provider of disposable products in the medical industry. The company believes that disposable products are the best choice for patient safety and hygiene. Disposable products minimize the risk of infection and contamination while improving hygiene in medical facilities.
Ambu is committed to minimizing the environmental impact of its products. The company uses environmentally friendly materials in the manufacture of its products and ensures that its products can be safely disposed of after use. Ambu strives to promote sustainability in all aspects of its business.
In summary, Ambu A/S is a leading provider of medical products that focuses on the development and marketing of innovative medical products. The company operates in three divisions and offers a wide range of products tailored to the needs of patients and medical professionals. Ambu is also committed to minimizing the environmental impact of its products and promoting sustainability. Ambu A/S is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Ambu A/S stock
EBIT per Share of Ambu A/S is 2.94 DKK in 2026.
EBIT per Share of Ambu A/S changed from 2.42 DKK to 2.94 DKK, representing a 21.48% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Ambu A/S since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Ambu A/S
All Key Metrics — Ambu A/S
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth